Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Insaf Hamdi"'
Autor:
Liadrine Moukendza Koundi, Ulrich Aymard Ekomi Moure, Funmilayo Grâce Boni, Insaf Hamdi, Lin Fan, Jianping Xie
Publikováno v:
Heliyon, Vol 10, Iss 5, Pp e27400- (2024)
Mycobacterium tuberculosis (M. tuberculosis) is the pathogen of human tuberculosis (TB). Resistance to numerous in vivo stresses, including oxidative stress, is determinant for M. tuberculosis intracellular survival, and understanding associated mech
Externí odkaz:
https://doaj.org/article/685c7ec767c3498ca7bf2eb4ff3f4cb6
Autor:
Funmilayo Grâce Boni, Insaf Hamdi, Liadrine Moukendza Koundi, Yongdong Dai, Kanshan Shrestra, Mohamed Abdellah Abokadoum, Ulrich Aymard Ekomi Moure, Ismail Mohamed Suleiman, Jianping Xie
Publikováno v:
Microbial Drug Resistance. 29:175-189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f26e5cb4e1587672cd3bc2d1e5483d7
https://doi.org/10.1089/mdr.2021.0239
https://doi.org/10.1089/mdr.2021.0239
Publikováno v:
Infection, Genetics and Evolution. 112:105445
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b8ecb0a5a82be2f1ac4d0eec88c6ec9
https://doi.org/10.1016/j.meegid.2023.105445
https://doi.org/10.1016/j.meegid.2023.105445
Publikováno v:
Microbial Drug Resistance. 27:768-775
Isoniazid (isonicotinic acid hydrazide, INH) is an effective frontline antituberculosis drug. INH targets several Mycobacterium tuberculosis processes, including mycolic acid biosynthesis, DNA synthesis, and redox potential. M. tuberculosis responds
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b4b1fcc0445d80eaaf2a3a35c1a59b8
https://doi.org/10.1089/mdr.2020.0179
https://doi.org/10.1089/mdr.2020.0179
Autor:
Funmilayo Grâce, Boni, Insaf, Hamdi, Liadrine, Moukendza Koundi, Yongdong, Dai, Kanshan, Shrestra, Mohamed Abdellah, Abokadoum, Ulrich Aymard, Ekomi Moure, Ismail Mohamed, Suleiman, Jianping, Xie
Publikováno v:
Microbial drug resistance (Larchmont, N.Y.).
Ethambutol (EMB) is used in combination with isoniazid and rifampicin for the treatment of tuberculosis caused by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e5356aa2a1dc5307bd0d70a8b4db415
https://pubmed.ncbi.nlm.nih.gov/35939307
https://pubmed.ncbi.nlm.nih.gov/35939307
Publikováno v:
Microbial drug resistance (Larchmont, N.Y.). 27(6)
Isoniazid (isonicotinic acid hydrazide, INH) is an effective frontline antituberculosis drug. INH targets several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::daf75000db027a872db64d1e23caa920
https://pubmed.ncbi.nlm.nih.gov/33211637
https://pubmed.ncbi.nlm.nih.gov/33211637
Publikováno v:
Infection, Genetics and Evolution. 97:105166
Tuberculosis is probably the most seasoned illness of the humanity. Intricacies or subsequent death emerging from these infections are frequently connected with cytokine storm. Interleukin-6 (IL-6) plays a crucial role in the immune response to tuber
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5150bd5cc9bb30763c7b5bc9a2c51679
https://doi.org/10.1016/j.meegid.2021.105166
https://doi.org/10.1016/j.meegid.2021.105166
Publikováno v:
TB & Outbreaks Week; 2024, p390-390, 1p
Publikováno v:
TB & Outbreaks Week; 10/6/2023, p1330-1330, 1p